Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer

2021 ◽  
Vol 13 (623) ◽  
Author(s):  
Christopher A. Chuckran ◽  
Anthony R. Cillo ◽  
Jessica Moskovitz ◽  
Abigail Overacre-Delgoffe ◽  
Ashwin S. Somasundaram ◽  
...  
2014 ◽  
Vol 93 (2) ◽  
pp. 113-119 ◽  
Author(s):  
Mauricio Campos‐Mora ◽  
Rodrigo A Morales ◽  
Francisco Pérez ◽  
Tania Gajardo ◽  
Javier Campos ◽  
...  

Author(s):  
Christopher J Nirschl ◽  
Christina Ceccato ◽  
Angela Alme ◽  
Brian Francica ◽  
Charles G Drake

2009 ◽  
Vol 27 (19) ◽  
pp. e5-e6 ◽  
Author(s):  
Cecile Badoual ◽  
Stephane Hans ◽  
Wolf H. Fridman ◽  
Daniel Brasnu ◽  
Susan Erdman ◽  
...  

2021 ◽  
Vol 6 (61) ◽  
pp. eabe4723
Author(s):  
Steffie Junius ◽  
Adamantios V. Mavrogiannis ◽  
Pierre Lemaitre ◽  
Margaux Gerbaux ◽  
Frederik Staels ◽  
...  

Regulatory T cells (Tregs) are indispensable for the control of immune homeostasis and have clinical potential as a cell therapy for treating autoimmunity. Tregs can lose expression of the lineage-defining Foxp3 transcription factor and acquire effector T cell (Teff) characteristics, a process referred to as Treg plasticity. The extent and reversibility of such plasticity during immune responses remain unknown. Here, using a murine genetic fate-mapping system, we show that Treg stability is maintained even during exposure to a complex microbial/antigenic environment. Furthermore, we demonstrate that the observed plasticity of Tregs after adoptive transfer into a lymphopenic environment is a property limited to only a subset of the Treg population, with the nonconverting majority of Tregs being resistant to plasticity upon secondary stability challenge. The unstable Treg fraction is a complex mixture of phenotypically distinct Tregs, enriched for naïve and neuropilin-1–negative Tregs, and includes peripherally induced Tregs and recent thymic emigrant Tregs. These results suggest that a “purging” process can be used to purify stable Tregs that are capable of robust fate retention, with potential implications for improving cell transfer therapy.


2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Kailash Singh ◽  
Marcus Hjort ◽  
Lina Thorvaldson ◽  
Stellan Sandler

Sign in / Sign up

Export Citation Format

Share Document